RFK Jr. says he has asked FDA to do a thorough review of mifepristone in light of a study indicating serious side effects could be 22x more common than the FDA says

HHS Secretary Robert F. Kennedy Jr. asks FDA for ‘complete review’ of abortion pill risks
Abortion Pill·By Bridget Sielicki
HHS Secretary Robert F. Kennedy Jr. asks FDA for ‘complete review’ of abortion pill risks
Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. announced Wednesday that he believes the Food and Drug Administration (FDA) should conduct a “complete review” of the abortion pill. The announcement comes after a recent analysis of insurance data published by the Ethics and Public Policy Center (EPPC) stated that “serious adverse events” (complications) of the abortion pill (mifepristone) occur at a rate far higher than the rate reported on the FDA’s drug label.
As reported by Live Action News:
[According to the EPPC,] nearly 11% of women (10.93%) experience sepsis, infection, hemorrhaging, or other serious or life-threatening adverse events following a mifepristone abortion. This means one in ten women experience at least one serious complication from taking mifepristone within 45 days — 22 times higher than the “less than 0.5 percent” serious adverse events rate reported by the FDA on the mifepristone label, according to this study.
The study authors state that serious adverse events in multiple categories were accounted for in the reported rate.
Research from the EPPC also claims that the failure rate of mifepristone is nearly double the failure rate currently listed on the FDA-approved drug label. Though the FDA label asserts a 2.6-3.8% failure rate for mifepristone abortions, the EPPC’s analysis states that real-world data shows a failure rate of 5.26.
Kennedy’s comments came during a Senate Health, Education, Labor, and Pensions Committee hearing, when Senator Josh Hawley referenced the EPPC report and asked Kennedy if he would look into the study’s findings.
“You have said you will do a top-to-bottom review. Do you continue to stand by that, and don’t you think that this new data shows the need to do a review is, in fact, very pressing?” Hawley asked.
“It’s alarming,” Kennedy said of the EPPC data, adding, “Clearly, it indicates that at the very least, the label should be changed. I’ve asked Marty Makary, who is the director of the FDA, to do a complete review and to report back.”
Kennedy said he did not have a sense of a timeline of when such a review would take place.
Last week, Hawley introduced legislation that would reinstate safety regulations surrounding the distribution of mifepristone while limiting the importation of the abortion pill and allow women harmed by the abortion pill to sue for damages. In a press release, Hawley referenced the EPPC report as reason why the FDA should restore the safeguards previously placed around the abortion pill.
“I’m introducing the Restoring Safeguards for Dangerous Abortion Drugs Act after a bombshell study revealed the truth about mifepristone: it’s dangerous,” he said. “The data shows 1 in 10 women who take mifepristone experience adverse health effects, like going to the ER or suffering from sepsis. The FDA needs to act to protect women now.”
Live Action News is pro-life news and commentary from a pro-life perspective.
Contact editor@liveaction.org for questions, corrections, or if you are seeking permission to reprint any Live Action News content.
Guest Articles: To submit a guest article to Live Action News, email editor@liveaction.org with an attached Word document of 800-1000 words. Please also attach any photos relevant to your submission if applicable. If your submission is accepted for publication, you will be notified within three weeks. Guest articles are not compensated (see our Open License Agreement). Thank you for your interest in Live Action News!
Read Next

Texas judge send abortion pill case back to Missouri
Cassy Cooke
·More In Abortion Pill

Abortion Pill
'Serious risk': Coalition urges HHS and FDA to pull abortion pill's approval
Kelli Keane
·
Abortion Pill
Despite promising a safety review, FDA approves another generic abortion pill
Nancy Flanders
·
Abortion Pill
State of Louisiana issues arrest warrant for California abortionist
Cassy Cooke
·
Abortion Pill
40 Days for Life calls for probe into pro-abortion ads in Florida
Angeline Tan
·
Abortion Pill
Louisiana woman seeks to join abortion pill lawsuit against FDA
Carole Novielli
·More From Bridget Sielicki

International
Dutch parliament rejects motion to declare abortion a 'human right'
Bridget Sielicki
·
Politics
Pro-abortion woman sentenced to five years in prison for threatening judge
Bridget Sielicki
·
Politics
Judge denies Planned Parenthood's request to halt Nevada parental notification law
Bridget Sielicki
·
Activism
Scottish grandmother arrested again for 'buffer zone' violation
Bridget Sielicki
·
Analysis
COURT RECORDS: KY cheerleader who put baby in closet heard him 'whimper'
Bridget Sielicki
·